Skip to Content


Ike Swetlitz, quoting Rachel E. Sachs (Academic Fellow Alumna)
STAT News
April 24, 2017

Read the Full Article

From the article:

Three lawyers who reviewed the case at the request of STAT said they could not think of another instance when a pharmaceutical company sued to protect the status of its medication on a state formulary.

“This is another really good example of how Mylan has attempted to use the law to their advantage at every turn to expand their market share,” said Rachel Sachs, an associate professor at the Washington University in St. Louis School of Law who specializes in health law. [...]

Read the full article here.

Read the Full Article

Tags

bioethics   fda   health care finance   health care reform   market   pharmaceuticals   public health   rachel sachs   regulation